Understanding Melasma
Melasma is characterized by symmetric gray-brown patches on sun exposed facial areas that often intensify with sun. These patches persist and may darken with ultraviolet exposure. In Korean dermatology, dermoscopy aids distinguishing melasma from other pigment disorders.
Treatment targets pigment reduction and trigger control with sun protection. Topical agents, energy devices, and tailored plans address melasma and dark spots. Progress is gradual and maintenance reduces relapse risk.
Causes and Triggers
Sun exposure remains the main driver of pigment overproduction in melasma and dark spots. Hormonal influences during pregnancy or therapy increase susceptibility. Genetic predisposition and inflammation also shape individual risk.
Seasonal sun and lifestyle fluctuations affect pigment stability. Irritation from products or procedures may trigger rebound darkening. Care plans consider skin type, climate, and daily habits.
Korean Derm Care
Korean dermatology integrates lasers, energy devices, and advanced topicals to treat melasma and dark spots. Common components include tranexamic acid, niacinamide, and retinoids. Rigid sun protection and supervised routines sustain durable results.
Clinical cases show improved outcomes when therapy is staged. Objective imaging tracks pigment changes to refine treatment plans. Noninvasive options like chemical peels and microneedling are selective.
Patch and Light Therapies
Patch and Light Therapies use patches or light energy to influence pigment. These approaches complement lasers and topicals while limiting downtime. Korean clinics sometimes trial patch regimens under medical supervision.
Some patches deliver tranexamic acid or antioxidants to modulate pigment. Light therapies such as selective laser or IPL suit melasma and dark spots patterns. Close monitoring helps detect rebound darkening and adjust care.